Journal international du développement et de la recherche sur les médicaments

  • ISSN: 0975-9344
  • Indice h du journal: 44
  • Note de citation du journal: 59.93
  • Facteur d’impact du journal: 48.80
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Scimago
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Publions
  • MIAR
  • Commission des bourses universitaires
  • Pub européen
  • Google Scholar
  • SHERPA ROMÉO
  • Laboratoires secrets des moteurs de recherche
  • ResearchGate
Partager cette page

Abstrait

Drug-Carrier Interaction Modelling for the Drug Release from Nanocarriers

Yanting Li*

For the administration and release of medicinal and imaging substances, numerous nanocarriers with different compositions and geometries have been produced. In order to achieve sustained release, many mechanisms like ion pairing and hydrophobic interaction need to be investigated due to the high specific surface areas of nanocarriers. Recently, we created a three-parameter model that takes into account first-order drug release from liposomes and reversible drug-carrier interaction. The analytical problem was solved in closed form. Here, we further investigate the model's capacity to represent the release of bioactive compounds from diverse nanocarriers, including medicines and growth factors. The model may be shown to be capable of mimicking the main types of drug release kinetics through a parameter research. More than 60 sets of experimental data from different drug delivery methods, including nanoparticles, hollow particles, fibers, and hollow fibers, were further fitted using the model. Additionally, bootstrapping is utilised in some circumstances to validate the model and assess the precision of parameter estimation. The model is practical for the design and development of novel drug delivery systems due to its simplicity, universality, and the physical clarity of each model parameter.

Keywords

Nanotechnology; Nanocarriers; Drug delivery; Drug targeting; Drug-carrier interaction